QOP
EVH icon

Quinn Opportunity Partners’s Evolent Health EVH Stock Holding History

Quinn Opportunity Partners’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$227K Hold
99,687
– – 0.01% 310
2025
Q4 		$399K Sell
99,687
-20,313
-17% -$113K 0.02% 299
2025
Q3 		$1.02M Hold
120,000
– – 0.07% 184
2025
Q2 		$1.35M Hold
120,000
– – 0.11% 163
2025
Q1 		$1.14M Buy
120,000
+30,000
+33% +$303K 0.08% 202
2024
Q4 		$1.01M Buy
+90,000
New +$1.58M 0.07% 200

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Quinn Opportunity Partners's EVH Position: Q1 2026 in Review

Quinn Opportunity Partners held its Evolent Health (EVH) position steady in Q1 2026 at 99,687 shares worth $227K. The position accounts for 0.01% of the portfolio, ranked #310.

Quinn Opportunity Partners first reported a position in EVH in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.35M in Q2 2025. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Quinn Opportunity Partners held 99,687 shares of Evolent Health worth $227K as of Q1 2026.
  • Quinn Opportunity Partners left its Evolent Health share count unchanged in Q1 2026.
  • Evolent Health made up 0.01% of Quinn Opportunity Partners's portfolio in Q1 2026, its #310 holding.
  • Quinn Opportunity Partners first reported a position in Evolent Health in Q4 2024 and has held it in 6 quarters since.
  • Quinn Opportunity Partners's Evolent Health position peaked at $1.35M in Q2 2025.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Quinn Opportunity Partners's 13F filing for Q1 2026, filed 15 May 2026.